News & Updates
Filter by Specialty:
Young-onset diabetes: Novel insights on management
At EmW 2025, Professor Andrea Luk from the Department of Medicine & Therapeutics, the Chinese University of Hong Kong, shared insights and recommendations on management of young-onset diabetes (YoD).
Young-onset diabetes: Novel insights on management
28 Oct 2025
HK data: LAI antipsychotics superior to oral antipsychotics in older patients with schizophrenia
Long-acting injectable (LAI) antipsychotics are associated with lower risks of disease relapse and mortality than oral antipsychotics in older patients with schizophrenia, a population-based study in Hong Kong has shown.
HK data: LAI antipsychotics superior to oral antipsychotics in older patients with schizophrenia
28 Oct 2025
Soft drinks may fuel depression via gut microbiome
Consumption of soft drinks predicts major depressive disorder (MDD) diagnosis and symptom severity in women through gut microbiota alterations, a cohort study has shown.
Soft drinks may fuel depression via gut microbiome
28 Oct 2025
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016
